Corrigendum: Cross-reactive humoral and CD4

CD4+ T cell SARS-CoV-2 antibody breakthrough infections hybrid immunity natural infection vaccination variants

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 08 08 2023
accepted: 09 08 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fimmu.2023.1241038.].

Identifiants

DOI: 10.3389/fimmu.2023.1274753 PMID: 37662943 PMC: PMC10469294
pubmed: 37662943
doi: 10.3389/fimmu.2023.1274753
pmc: PMC10469294
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1274753

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Martel, Cuervo-Rojas, Ángel, Ariza, González, Ramírez-Santana, Acosta-Ampudia, Murcia-Soriano, Montoya, Cardozo-Romero, Valderrama-Beltrán, Cepeda, Castellanos, Gómez-Restrepo, Perdomo-Celis, Gazquez, Dickson, Brien, Mateus, Grifoni, Sette, Weiskopf and Franco.

Auteurs

Fabiola Martel (F)

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Juliana Cuervo-Rojas (J)

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Juana Ángel (J)

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Beatriz Ariza (B)

Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.

John Mario González (JM)

Group of Basic Medical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia.

Carolina Ramírez-Santana (C)

Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

Yeny Acosta-Ampudia (Y)

Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

Luisa Murcia-Soriano (L)

Hospital Universitario Mayor-Méderi, Universidad El Rosario, Bogotá, Colombia.

Norma Montoya (N)

Head Clinical Laboratory Unit, Clínica del Occidente, Bogotá, Colombia.

Claudia Cecilia Cardozo-Romero (CC)

Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.

Sandra Liliana Valderrama-Beltrán (SL)

Division of Infectious Diseases, Department of Internal Medicine. School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio Infectious Diseases Research Group, Bogotá, Colombia.

Magda Cepeda (M)

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Julio César Castellanos (JC)

General Direction, Hospital Universitario San Ignacio, Bogotá, Colombia.

Carlos Gómez-Restrepo (C)

Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Federico Perdomo-Celis (F)

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Andreu Gazquez (A)

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.

Alexandria Dickson (A)

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.

James D Brien (JD)

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.

José Mateus (J)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.

Alba Grifoni (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.

Alessandro Sette (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States.

Daniela Weiskopf (D)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.

Manuel A Franco (MA)

Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Classifications MeSH